Trial Profile
Pregnancy Outcomes in Multiple Sclerosis Populations Exposed and Unexposed to Interferon β - a Register-based Study in the Nordic Countries
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon beta-1b (Primary) ; Interferon beta-1a
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bayer
- 31 Aug 2018 Status changed from recruiting to completed.
- 18 May 2018 Planned End Date changed from 30 Apr 2018 to 31 May 2019.
- 18 May 2018 Planned primary completion date changed from 30 Apr 2018 to 31 Jan 2019.